PRNP and prion disease: Consequently, only six treatments for prion diseases were advanced to the stage of clinical evaluations: flupirtine, quinacrine, doxycycline, pentosan polysulfate, anti-PrPSc monoclonal antibody PRN100, and a PRNP antisense oligonucleotide (ASO) [25,85].